The Connected Drug Delivery Devices Market is projected to grow from USD 646.3 million in 2022 to USD 3.54 billion by 2029. This growth is driven by the increasing prevalence of chronic diseases, rising geriatric population, and patient awareness of therapy adherence. Connected drug delivery devices are wireless and smart electronic devices that allow patients to self-administer therapy.
Request Sample of Report @ https://www.aarkstore.com/medical-devices/1883092/global-connected-drug-delivery-devices-market
The COVID-19 pandemic initially boosted the market as care shifted to home-based technologies, but the market is expected to maintain stable growth. Key drivers include chronic disease prevalence, patient connectivity, and engagement.
For more information, visit our category page @ https://www.aarkstore.com/market-research-reports-categories
Market Segmentation
The market is segmented based on various factors, including product, technology, end user, and geography.
Integrated connected devices dominate the market, driven by technological advancements, increased adoption of connected inhaler devices, and product launches. Bluetooth technology holds the largest share among technology segments, thanks to its widespread availability in smartphones and ease of access.
The homecare segment is expected to dominate the market, driven by the increasing use and adoption of connected drug delivery devices in home settings. This segment will experience significant growth due to the rising cases of cardiovascular diseases (CVDs), diabetes, chronic obstructive pulmonary disease (COPD), and other chronic diseases that require proper health record maintenance. Innovations in connected drug delivery devices will further boost segment growth.
Get the Complete Report & TOC @ https://www.aarkstore.com/medical-devices/1883092/global-connected-drug-delivery-devices-market
In February 2022, Aptar Pharma, a well-known global provider of drug delivery systems, launched the HeroTracker Sense in the United States. This innovative solution enhances a standard metered dose inhaler (pMDI) by transforming it into a smart connected healthcare device for digital respiratory health.
TABLE OF CONTENTS
PART 1. INTRODUCTION
Description
Objectives of The Study
Market Segment
PART 2. RESEARCH METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
PART 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET BY PRODUCT
Connected sensors
Integrated connected devices
PART 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET BY TECHNOLOGY
Bluetooth
Near-field communication (NFC)
Others
PART 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET BY END USER
Healthcare providers
Homecare settings
PART 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET BY GEOGRAPHY
PART 9. COMPANY PROFILES
Follow Us on LinkedIn | Twitter | Facebook
About Aarkstore Enterprise
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialise in providing online market business information on market research reports, books, magazines, and conferences at competitive prices, and strive to provide excellent and innovative service to our customers.
Contact Info
Aarkstore Enterprise
Phone: +91 – 22 2756 4963 24/7
Online Support: +91 9987295242
Email: [email protected]